Jump to main content
eTG Complete
Index
Search
Home
Addiction
Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
Addiction
What is covered in the Addiction guidelines?
Overview of substance use and addictive behaviours
Tobacco smoking and nicotine dependence
Alcohol: hazardous, harmful and dependent use
Opioids: hazardous, harmful and dependent use
Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
Cannabis: hazardous, harmful and dependent use
Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
Overview of disorders of GHB use
Screening and assessment of GHB use
Overview of management of disorders of GHB use
Management of GHB withdrawal
References
Hallucinogens: hazardous and harmful use
Ketamine: hazardous and harmful use
Pregabalin and gabapentin: hazardous, harmful and dependent use
Quetiapine and other antipsychotics: hazardous, harmful and dependent use
Sedating antihistamines: hazardous, harmful and dependent use
Stimulants: hazardous, harmful and dependent use
Volatile inhalants: hazardous, harmful and dependent use
Addictive behaviours
Key resources for substance use and addictive behaviours
Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
Published
June 2023
Overview of disorders of GHB use
Screening and assessment of GHB use
Overview of management of disorders of GHB use
Management of GHB withdrawal
